Status:
COMPLETED
The Effect of Lactobacillus Reuteri Probiotic as an Adjunct Treatment for Helicobacter Pylori Infection in Adults
Lead Sponsor:
Universiti Kebangsaan Malaysia Medical Centre
Collaborating Sponsors:
Y.S.P. Industries (M) Sdn. Bhd, Menara LGB, Taman Tun Dr Ismail, 60000 Kuala Lumpur, Malaysia
Conditions:
Helicobacter Pylori Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective, randomised, double-blind, placebo-controlled trial involving newly diagnosed Helicobacter pylori (H. pylori) patients. Patients will be prescribed with standard triple therapy f...
Detailed Description
The prime discovery of Helicobacter pylori (H. pylori) in chronic gastritis patients by Marshall and Warren in 1982 has geared a frenetic pace in H. pylori research. H. pylori is a helix-shaped microa...
Eligibility Criteria
Inclusion
- Aged 18-year-old and above
- Confirmed H. pylori diagnosis
- Informed consent to participate in the study
Exclusion
- Any active gastrointestinal disease
- Previous surgical procedures affecting the gastrointestinal tract, e.g., bariatric surgery or gastrectomy
- Pregnancy or breastfeeding women
- Previous allergy to probiotics
- Intake of proton pump inhibitor, H2 antagonist or antibiotics in the past 3 months
- Recent diagnosis of advanced stage of malignancy
- Recent acute gastroenteritis within 4 weeks
- Recent history of traditional medication intake
- Recent failure of first line eradication therapy for H. pylori
Key Trial Info
Start Date :
December 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 10 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05399862
Start Date
December 24 2020
End Date
January 10 2022
Last Update
June 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Malaysia Medical Centre
Cheras, Kuala Lumpur, Malaysia, 56000